BACKGROUND AND AIMS Many uncertainties remain regarding optimal therapies and strategies for the treatment of inflammatory bowel disease. Setting research priorities addressing therapies requires a partnership between health care professionals, patients and organisations supporting patients. We aimed to use the structure of the James Lind Alliance Priority Setting Partnership, which has been us...

The two main diseases of inflammatory bowel disease are Crohn's disease and ulcerative colitis. The pathogenesis of inflammatory disease is that abnormal intestinal inflammations occur in genetically susceptible individuals according to various environmental factors. The consequent process results in inflammatory bowel disease. Medical treatment consists of the induction of remission in the acu...

Patients with inflammatory bowel disease have an additional risk of developing cancer compared with the general population. This is due to local chronic inflammation that leads to the development of gastrointestinal cancers and the use of thiopurines, associated with a higher risk of lymphoproliferative disorders, skin cancers, or uterine cervical cancers. Similar to the general population, a p...

Anaemia is a common complication associated with inflammatory bowel diseases (Crohn's disease and ulcerative colitis). It substantially impairs quality of life, makes therapy more complicated, and increases costs of treatment. It seems that anaemia therapy is suboptimal in this group of patients in the Polish population. The recommendations presented below provide iron deficiency anaemia manage...

Inflammatory bowel disease is highly associated with an option of potential surgical treatment. Variety of surgical methods require detailed and appropriate patient preparation for the operation. In our study we tried to present some problems in dealing with patients with inflammatory bowel disease in aspect of perioperative period. We discussed methods of solving these problems and expected ef...

Inflammatory bowel disease (IBD) is associated with several extra-intestinal complications, including venous thromboembolism (VTE). In patients IBD, VTE occurs at younger age and higher recurrence mortality rates as compared to without IBD. The risk appears be during active hospitalization. this review we target the importance of prophylaxis aim describe strategies for treatment in More awarene...

Among the extraintestinal manifestations of inflammatory bowel disease (IBD), pyoderma gangrenosum (PG) often poses a therapeutic challenge. We describe two cases of PG associated with inflammatory bowel disease, who responded to treatment with Infliximab. © 2011 Elsevier España, S.L. All rights reserved. Pioderma gangrenoso asociado a enfermedad inflamatoria intestinal. Descripción de 2 casos ...

Purpose Ulcerative Colitis (UC) is a chronic inflammatory bowel disease with a relapsing and remitting course. The prolonged use of conventional standard drugs often produces mild to severe side effects and may eventually result in drug resistance. Hence, there is a need for effective and safe complementary treatment options. In Ayurveda various treatment modalities for chronic inflammatory bow...

BACKGROUND Infection with gastrointestinal cytomegalovirus in an immunocompetent host is a rather rare occurrence in the literature. There are a few reports of gastrointestinal infection in the immunocompetent who are then subsequently given a new diagnosis of inflammatory bowel disease. It is speculated that the initial cytomegalovirus colitis infection triggers the onset of inflammatory bowel...

Over the past decade, while gastroenterologists' interest in mind-body interactions in organic disorders dwindled, stronger evidence has linked psychosocial factors with the incidence and recurrence of peptic ulcer and with the course of inflammatory bowel disease. Psychological-behavioral approaches to treatment continue to be disappointing. Psychosocial factors may affect ulcer by increasing ...